Dr Jiwon Oh looks forward to hearing updates on major clinical trials and long-term studies of new and emerging MS treatments at ECTRIMS 2025.

A North Hampshire woman is marking ten years since being diagnosed with multiple sclerosis (MS) by leading a 47-mile charity ...

Columnist Ben Hofmeister worries about his MS cognitive symptoms worsening and wonders if he'll even be aware of the changes.

AlterEgo's neural-interface device is non-invasive and is being tested in people with multiple sclerosis and amyotrophic ...

Drs Anne Cross and Scott Newsome discuss new horizons in MS treatment strategies, including the TREAT-MS trial and shared decision-making for optimal patient care.

An update from Contineum Therapeutics, Inc. Class A ( ($CTNM) ) is now available. On September 18, 2025, Contineum Therapeutics announced positive ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...

Key Takeaways Most neurologists treating multiple sclerosis have receive payments from pharma firmsThose who prescribe high ...

Yas Clinic- Khalifa city, and Abu Dhabi Stem Cells Center (ADSCC) have announced a pioneering collaboration that brings new, AI-supported MRI analys ...

For more than 60 years, the medical community has been refining the diagnosis of multiple sclerosis. The diagnosis of multiple sclerosis typically involves the detection of demyelinating episodes that ...